MedPath
FDA Approval

ERLEADA

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Janssen Products, LP
DUNS: 804684207
Effective Date
January 17, 2024
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Apalutamide(240 mg in 1 1)

Manufacturing Establishments6

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Janssen Pharmaceuticals, Inc.

Janssen Products, LP

080236951

Janssen Pharmaceutica NV

Janssen Products, LP

400345889

Janssen Cilag SpA

Janssen Products, LP

542797928

Johnson & Johnson Private Limited

Janssen Products, LP

677603030

Janssen Ortho LLC

Janssen Products, LP

805887986

Catalent Pharma Solutions, LLC

Janssen Products, LP

829672745

Products2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

ERLEADA

Product Details

NDC Product Code
59676-604
Application Number
NDA210951
Marketing Category
NDA (C73594)
Route of Administration
ORAL
Effective Date
January 17, 2024
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
HYPROMELLOSE ACETATE SUCCINATE 16070722 (3 MPA.S)Inactive
Code: 24P2YXD2PWClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61UClass: IACT
GLYCERYL MONOCAPRYLOCAPRATEInactive
Code: G7515SW10NClass: IACT
FERROSOFERRIC OXIDEInactive
Code: XM0M87F357Class: IACT
POLYVINYL ALCOHOL GRAFT POLYETHYLENE GLYCOL COPOLYMER (3:1; 45000 MW)Inactive
Code: 23ZQ42JZZHClass: IACT
POLYVINYL ALCOHOL, UNSPECIFIEDInactive
Code: 532B59J990Class: IACT
TALCInactive
Code: 7SEV7J4R1UClass: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JPClass: IACT
Code: 4T36H88UA7Class: ACTIBQuantity: 240 mg in 1 1

ERLEADA

Product Details

NDC Product Code
59676-600
Application Number
NDA210951
Marketing Category
NDA (C73594)
Route of Administration
ORAL
Effective Date
January 17, 2024
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
HYPROMELLOSE ACETATE SUCCINATE 16070722 (3 MPA.S)Inactive
Code: 24P2YXD2PWClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61UClass: IACT
FERROSOFERRIC OXIDEInactive
Code: XM0M87F357Class: IACT
FERRIC OXIDE YELLOWInactive
Code: EX438O2MRTClass: IACT
POLYETHYLENE GLYCOL, UNSPECIFIEDInactive
Code: 3WJQ0SDW1AClass: IACT
POLYVINYL ALCOHOL, UNSPECIFIEDInactive
Code: 532B59J990Class: IACT
TALCInactive
Code: 7SEV7J4R1UClass: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JPClass: IACT
Code: 4T36H88UA7Class: ACTIBQuantity: 60 mg in 1 1
© Copyright 2025. All Rights Reserved by MedPath